Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
13,110
+10 (0.08%)
At close: Feb 25, 2026
275.11% (1Y)
| Market Cap | 362.85B +277.3% |
| Revenue (ttm) | 108.14B +5.8% |
| Net Income | 1.41B |
| EPS | 60.34 |
| Shares Out | 27.68M |
| PE Ratio | 217.28 |
| Forward PE | n/a |
| Dividend | 30.00 (0.23%) |
| Ex-Dividend Date | Mar 3, 2026 |
| Volume | 2,007,992 |
| Average Volume | 4,488,191 |
| Open | 13,200 |
| Previous Close | 13,100 |
| Day's Range | 13,000 - 13,940 |
| 52-Week Range | 2,995 - 15,960 |
| Beta | 0.82 |
| RSI | 58.37 |
| Earnings Date | n/a |